RxDoctor Payments DataLook up a doctor →

Jeremy Green, MD

Dermatology · Coral Gables, FLNPI 1225249055

Payments from drug & device makers

$2,190,652in general payments, 2019–2025

Across 831 payments — averaging $2636.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$855K
  • Merz North America, Inc.$840K
  • Evolved By Nature, Inc.$223K
  • Endo Pharmaceuticals Inc.$172K
  • Galderma Laboratories, L.p.$84K
  • Ipsen Innovation$10K
  • plus $7K from 32 others
$12,424in research payments, 2019–2025

Across 10 payments — averaging $1242.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$12K
  • Endo Pharmaceuticals Inc.$200

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,190,652 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida

Medicare billing

Part B allowed, 2024
$72,188
Medicare patients
193
Services billed
1,324

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Coral Gables

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →